GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Leadman Biochemistry Co Ltd (SZSE:300289) » Definitions » EBIT per Share

Beijing Leadman Biochemistry Co (SZSE:300289) EBIT per Share : ¥-0.02 (TTM As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Leadman Biochemistry Co EBIT per Share?

Beijing Leadman Biochemistry Co's EBIT per Share for the three months ended in Sep. 2024 was ¥0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.02.

During the past 12 months, the average EBIT per Share Growth Rate of Beijing Leadman Biochemistry Co was -90.70% per year. During the past 3 years, the average EBIT per Share Growth Rate was -16.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was -20.60% per year. During the past 10 years, the average EBIT per Share Growth Rate was -16.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Beijing Leadman Biochemistry Co's EBIT per Share or its related term are showing as below:

SZSE:300289' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -25.8   Med: -12.6   Max: 36.3
Current: -16.3

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Beijing Leadman Biochemistry Co was 36.30% per year. The lowest was -25.80% per year. And the median was -12.60% per year.

SZSE:300289's 3-Year EBIT Growth Rate is ranked worse than
73.95% of 714 companies
in the Medical Devices & Instruments industry
Industry Median: 6.75 vs SZSE:300289: -16.30

Beijing Leadman Biochemistry Co's EBIT for the three months ended in Sep. 2024 was ¥1.9 Mil.


Beijing Leadman Biochemistry Co EBIT per Share Historical Data

The historical data trend for Beijing Leadman Biochemistry Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Leadman Biochemistry Co EBIT per Share Chart

Beijing Leadman Biochemistry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 -0.03 0.14 -0.04 0.05

Beijing Leadman Biochemistry Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 -0.03 - 0.01 -

Beijing Leadman Biochemistry Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Beijing Leadman Biochemistry Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

EBIT per Share(A: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=25.187/511.246
=0.05

Beijing Leadman Biochemistry Co's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

EBIT per Share(Q: Sep. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=1.929/505.369
=0.00

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Leadman Biochemistry Co  (SZSE:300289) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Beijing Leadman Biochemistry Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Beijing Leadman Biochemistry Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Leadman Biochemistry Co Business Description

Traded in Other Exchanges
N/A
Address
No.5 Hongda South Road, Beijing, CHN
Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.
Executives
Ding Yao Liang Executives
Wang Xiao Hong Supervisors
Zhang Hai Tao Executives
Zhang Ya Li Supervisors
Sun Qian Director
Wang Jian Hua Directors, executives
Wang Yi Xing Directors, executives
Yang Lu Ping Securities Affairs Representative
Niu Ju Hui Secretary Dong
Zhang Kun Director
Shen Guang Qian Directors, executives
Ma Yan Wen Director
Wang Lan Zhen Directors, executives

Beijing Leadman Biochemistry Co Headlines

No Headlines